​Safety of Teva’s medicines are of paramount importance to us.

Once a medicine has been released on the market, physicians, patients, healthcare teams and other caregivers can report side effects and safety concerns. These can either be reported to Teva directly or to the local authorities. All Teva employees attend a pharmacovigilance training course, to ensure effective collection of safety data within our organization.

Additionally, Teva takes active measures to analyse all collected safety data:

  • Signal Detection: A periodic review, whereby the safety profile of each product is analysed and evaluated to identify any possible new safety issues
  • Periodic Safety Update Report: A comprehensive report submitted to the authorities that includes safety data and analysis of risk-benefit profile
  • Risk Management Plan: Based on a specific product’s safety profile, Teva suggests additional activities to monitor, minimize or prevent identified and potential risks and adverse events

Teva's Pharmacovigilance unit safety professionals are responsible for monitoring, identifying, analysing and reporting potential safety risks.

Our pharmacovigilance team:

  • Takes an active part in the studies during the investigational stage, monitoring the safety of medicines in clinical use by collecting adverse events
  • Maintains an advanced database of all reported side effects that is used for effective collection, assessment and prevention of adverse events
  • Actively reviews patient side effects reported by patients, carers or health care professionals
  • Uses sophisticated techniques, computer analytics and clinical judgment to determine the possibility of a new risk once a medicine is marketed
  • Is continuously monitored by regulatory authorities
  • Engages external advisory panels to ensure patient safety
  • Is involved in studies conducted with marketed Teva products

We encourage patients and caregivers to contact us or their physicians if they experience any side effect that might be related to one of our medicines. Local contact information can be found on many of our medicine package, alternatively, please contact your local safety department on 1800 AU TEVA (1800 288 382) or via e-mail at